Skip to main content

Table 4 Non-recurrent vs. recurrent patients in the larger-tumor group (n = 22)

From: Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy

 

All 22 patients

Non-recurrent (n = 13)

Recurrent (n = 9)

p value

Tumor diameter

27.0, 23.0–34.0

26.0, 22.0–33.0

28.0, 26.0–35.0

0.331

FDG SUVmax

8.59, 6.17–11.8

6.98, 5.38–9.79

9.73, 8.46–13.21

0.015

FDG MTV

8.06, 5.09–10.42

6.60, 1.89–9.15

8.09, 3.52–10.8

0.973

FMISO SUVmax

1.70, 1.41–2.32

1.42, 0.94–1.67

2.21, 1.90–2.74

0.002

FMISO TMR

1.45, 1.05–1.94

1.07, 0.72–1.54

2.22, 1.79–2.44

0.001

FMISO TBR

1.13, 0.81–1.49

0.91, 0.63–1.12

1.70, 1.37–1.80

0.002

  1. Abbreviations are explained in Table 2 footnote